As of April 19, 2025, Kyverna Therapeutics (KYTX) has a market cap of $80.387 million USD. According to our data, Kyverna Therapeutics is ranked No.7739 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $80.39 M |
-50.21%
|
Dec 31, 2024 | $0.16 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() Sana Biotechnology
SANA
|
$0.37 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$52.96 M |
-0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$61.27 M |
0.051 M
|
![]() UK
|
![]() Iovance Biotherapeutics
IOVA
|
$1.00 B |
-0.000 M
|
![]() USA
|
![]() Atara Biotherapeutics
ATRA
|
$36.15 M |
0.000 M
|
![]() USA
|
Market Cap | = | KYTX Stock Price | * | KYTX Shares Outstanding |
= | $1.86 | * | 43.22 M | |
= | $80.39 M |